OSNOVNYE PRINTsIPY VEDENIYa BOL'NOGO, PERENESShEGO IShEMIChESKIY INSUL'T


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article considers the modern approaches to the treatment of patients after ischemic stroke (IS). Improving the effectiveness of rehabilitation can be achieved through administration of drugs with neuroprotective and neurotrophic actions, which include Cellex, a tissue-specific protein-peptide complex of fetal tissue of farm animals. The drug was clinically tested and currently is registered as a treatment for patients with acute cerebrovascular diseases as a part of combined therapy in acute and early periods of rehabilitation. Preliminary studies have demonstrated good tolerability of Cellex, and its good compatibility with other drugs.

Full Text

Restricted Access

References

  1. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М., 2001. 327 c.
  2. Гусев Е.И, Скворцова В.И., Стаховская Л.В. Эпидемиология инсульта в России. Инсульт// Журн. неврол. и психиатр. им. С.С. Корсакова (приложение). 2003. № 8. С. 4-9.
  3. Гусев Е.И., Камчатнов П.Р. Пластичность головного мозга в норме и патологии // Журн. неврол. и психиатр, им. С.С. Корсакова. 2004. № 2. С. 73-80.
  4. Романова Г.А, Шакова Ф.М., Барсков И.В. и др. Функциональные и морфологические повреждения при фокальной ишемии префронтальной коры головного мозга крыс; коррекция с помощью препарата целлекс // Журн. неврол. и психиатр. им. С.С. Корсакова. 2011. № 5. С. 34-9.
  5. Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373(9678):1849-60.
  6. Cappa S, Benke T, Clarke S, et al. Members of the Task Force on Cognitive Rehabilitation. EFNS guidelines on cognitive rehabilitation: report of an EFNS task force. Eur J Neurol 2005; 12:665-80.
  7. Cauraugh H, Summers J. Neural plasticity and bilateral movements: A rehabilitation approach for chronic stroke. Prog Neurobiol 2005;75:309-20.
  8. Coull A, Lovett J, Rothwell P. Oxford Vascular Study. Population based study of early risk of stroke after transient ischemic attack or minorstroke: implications for public education and organization of services. BMJ 2004;328:326-28.
  9. Felmeden D, Lip G. Antithrombotic therapy in hypertension: a Cochrane Systematic review. J Human Hypertension 2005;19:185-96.
  10. Ferrarello F, Baccini M, Rinaldi L, et al. Efficacy of physiotherapy interventions late after stroke: a meta-analysis. J Neurol Neurosurg Psychiatry 2011;82:136-43
  11. Fitzgerald B, Cohn S, Klein A. Stroke prevention in atrial fibrillation: Current anticoagulation management and future directions. Cleveland Clin J Med 2005;72(1):24-30.
  12. Gage B, Waterman A, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.
  13. Kissela B, Lindsell C, Kleindorfer D, et al. Clinical Prediction of Functional Outcome After Ischemic Stroke. The Surprising Importance of Periventricular White Matter Disease and Race. Stroke 2009;40:530-36.
  14. Kluding P, Gajewski B. Lower-Extremity Strength Differences Predict Activity Limitations in People With Chronic Stroke. Phys Ther 2009; 89(1):73-81.
  15. Lip G, Kamath S, Hart R. ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders. BMJ 2002;325:1161-63.
  16. Lovett J, Coull A, Rothwell P. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569-73.
  17. Olesen J, Lip G, Hansen M, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011 Jan 31;342:d124. doi: 10.1136/bmj.d124.
  18. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
  19. Robinson R, Jorge R, Moser D, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299(20):2391 -400.
  20. Sacco R, Adams R, Albers G, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: The American Academy of Neurology affirms the value of this guideline. A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke. Circulation 2006;113;e409-e449.
  21. Vermeer S.E, Hollander M, Van Dijk E, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34:1126-29.
  22. Williams B, Poulter N.R, Brown M.J, Davis M, McInnes G.T, Potter J.F; the BHS guidelines working party, for the British Hypertension Society. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV). BMJ 2004;328:634-40.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies